Mehran Contrast-Induced Nephropathy Risk Score Predicts Short- and Long-Term Clinical Outcomes in Patients With ST-Elevation–Myocardial Infarction
- 1 October 2010
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation: Cardiovascular Interventions
- Vol. 3 (5), 491-498
- https://doi.org/10.1161/circinterventions.110.955310
Abstract
The Mehran Risk Score (MRS) has been demonstrated to be clinically useful for prediction of contrast-induced nephropathy (CIN) after nonurgent percutaneous coronary intervention. We aim to validate the MRS in the setting of Primary percutaneous coronary intervention for prediction of both CIN and short- and long-term clinical outcomes. We assigned 891 consecutive patients with ST-elevation–myocardial infarction undergoing primary percutaneous coronary intervention to 4 groups of risk of CIN (RC) according to MRS (low, medium, high, and very high risk). We evaluated CIN, death, and major cardiovascular and cerebrovascular events after 25 months' mean follow-up. At multivariable analysis, mortality in very high-risk group was more than 10-fold higher (hazard ratio [HR], 10.11; 95% confidence interval [CI], 4.83 to 21.1; P P P P P =0.001), and medium-risk group (HR, 1.42; 95% CI, 1.10 to 1.85; P =0.007). In addition, the HR for rehospitalization increased with the increasing RC groups (HR, 3.32; 95%CI, 1.96 to 5.63; P P =0.008; HR, 7.73; 95% CI, 2.97 to 20.10; P P =0.021) in the very high RC group, 1.33 (95% CI, 0.68 to 2.61; P =0.398) in the high RC group, and 1.10 (95% CI, 0.67 to 1.79; P =0.699) in the medium RC group, as compared with the lower one. The MRS may be applied in the primary angioplasty setting population and is able to predict CIN and to stratify patients for poor clinical outcomes both in the short- and long-term follow-up.Keywords
This publication has 30 references indexed in Scilit:
- Contrast-Induced Acute Kidney InjuryJournal of the American College of Cardiology, 2008
- Contrast‐Induced NephropathyJournal of Interventional Cardiology, 2007
- Low hematocrit predicts contrast-induced nephropathy after percutaneous coronary interventionsKidney International, 2005
- Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarctionJournal of the American College of Cardiology, 2004
- Incidence and Prognostic Importance of Acute Renal Failure After Percutaneous Coronary InterventionCirculation, 2002
- The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventionsJournal of the American College of Cardiology, 2002
- Acute Renal Failure After Coronary Intervention: Incidence, Risk Factors, and Relationship to MortalityThe American Journal of Medicine, 1997
- Incidence, Risk Factors, and Clinical Course of Acute Renal Insufficiency After Cardiac Catheterization in Patients 70 Years of Age or OlderArchives of Internal Medicine, 1990
- Nephrotoxicity from angiographic contrast materialThe American Journal of Medicine, 1982
- Coronary Angiography and Acute Renal Failure in Diabetic Azotemic NephropathyAnnals of Internal Medicine, 1977